ID   TS-RM-1
AC   CVCL_W501
SY   TS-RM1
DR   Cosmic; 1718362
DR   Cosmic; 2356031
DR   Wikidata; Q54973055
RX   PubMed=7669751;
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Characteristics: Established from a transplanted tumor (TS-RM-1nu) in BALB/c nu/nu mice.
CC   Doubling time: 31 hours (PubMed=7669751).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-10-20; Version: 10
//
RX   PubMed=7669751;
RA   Kaneko S., Kaneko M., Ohkawa H.;
RT   "Establishment and characterization of a childhood embryonal
RT   rhabdomyosarcoma cell line with nonrandom chromosome alterations.";
RL   Hum. Cell 8:35-41(1995).
//
RX   PubMed=22142829; DOI=10.1158/1078-0432.CCR-11-2056;
RA   Shukla N., Ameur N., Yilmaz I., Nafa K., Lau C.-Y., Marchetti A.,
RA   Borsu L., Barr F.G., Ladanyi M.;
RT   "Oncogene mutation profiling of pediatric solid tumors reveals
RT   significant subsets of embryonal rhabdomyosarcoma and neuroblastoma
RT   with mutated genes in growth signaling pathways.";
RL   Clin. Cancer Res. 18:748-757(2012).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//